|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$81,904.14 |
2.78% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$78,734.87 |
2.67% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$77,568.80 |
2.63% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$77,284.86 |
2.62% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$74,208.15 |
2.52% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$70,893.74 |
2.40% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$69,136.81 |
2.35% |
| Waters Corporation |
WAT |
941848103 |
184 |
$69,391.92 |
2.35% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$68,531.67 |
2.32% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$68,015.96 |
2.31% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$67,251.42 |
2.28% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$66,751.92 |
2.26% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$64,883.74 |
2.20% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$64,753.47 |
2.20% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$63,888.25 |
2.17% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$63,839.27 |
2.17% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$62,726.08 |
2.13% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$61,915.78 |
2.10% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$61,741.44 |
2.09% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$61,175.84 |
2.08% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$60,753.80 |
2.06% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,612.39 |
2.06% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$60,577.80 |
2.05% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$60,550.15 |
2.05% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,804.56 |
1.99% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$57,960.90 |
1.97% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$57,624.70 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
265 |
$57,240.00 |
1.94% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$56,917.14 |
1.93% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,669.25 |
1.92% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,595.10 |
1.92% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$56,482.59 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$55,695.64 |
1.89% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$55,507.20 |
1.88% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$53,703.30 |
1.82% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$53,780.10 |
1.82% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$53,501.50 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$53,292.76 |
1.81% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$52,633.60 |
1.79% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$52,335.57 |
1.78% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$52,212.90 |
1.77% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$52,220.52 |
1.77% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,621.70 |
1.72% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,969.28 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$47,487.00 |
1.61% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$45,691.70 |
1.55% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,861.73 |
1.52% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$42,965.45 |
1.46% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$41,540.51 |
1.41% |
| US Dollar |
$USD |
|
14,464 |
$14,464.20 |
0.49% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|